LifeTech Scientific Corporation
1302.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.94B
Close$
$1.75
23% upside
Current Fair Value
23% upsideUndervalued by 23% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.94 Billion |
|---|---|
| Enterprise Value | $5.00 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.03 |
| Beta | 0.33 |
| Outstanding Shares | 4,383,710,000 |
Return
| Return on Equity | 3.93% |
|---|---|
| Return on Assets | 2.74% |
| Return on Invested Capital | 6.23% |
Valuation & Multiples
| P/E Ratio | 90.49 |
|---|---|
| PEG | -55.73 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.91 |
| Enterprise Value to EBIT | 20.56 |
| Enterprise Value to Net Income | 38 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
March 31, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About LifeTech Scientific Corporation
1,245 employees
CEO: Yue Hui Xie LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asi...